Results

Total Results: 1,185 records

Showing results for "author year description".

21. Effectiveness of Recombinant Human Growth Hormone in the Treatment of Cystic Fibrosis — Research Protocol Document | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/cystic-fibrosis-hgh/research-protocol
    January 22, 2010 - The median age of survival has improved consistently from 1955 (5 year survival) to 1969 (14 year survival … ), 1985 (25 year survival), and to the most recent data in 2006 (37 year survival) [ 2 ]. … The following information will be obtained from each trial, where applicable: author identification, … The template will be provided to the author with their published trial or study-specific data filled … in and the author will be invited to provide any additional data.

22. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/cystic-fibrosis-hgh_research-protocol.pdf
    August 22, 2008 - The median age of survival has improved consistently from 1955 (5 year survival) to 1969 (14 year survival … ), 1985 (25 year survival), and to the most recent data in 2006 (37 year survival).2 The estimated annual … The following information will be obtained from each trial, where applicable: author identification, … The template will be provided to the author with their published trial or study-specific data filled … in and the author will be invited to provide any additional data.

23. EHC Protocol: Addressing Social Isolation To Improve Health of Older Adults: A Rapid Evidence Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-patient-family-engagement.pdf
    July 01, 2023 - Description of Included Studies To efficiently describe eligible studies, the full text of each potentially … reviewed by a single team member to confirm eligibility and prepare a summary of the study, including author … , year, study design, number of study participants, and main findings relevant to each of our review … To describe eligible systematic reviews, a single team member will prepare a summary including the author … , year, number of studies by study design, and main findings relevant to each of our review questions

24. Medicare Prescription Drug Data Development: Methods for Improving Patient Safety and Pharmacovigilance Using Observational Data | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/patient-safety-databases-prescriptions/research
    August 26, 2008 - Observational Data Research Report August 26, 2008 Download Main Document PDF 1 MB Author … Field Description: Num (3) Field Name: Age1 Label: Single year age, 50+ Definition: Time-dependent … SM = Separated more than 1 year WI = Widowed Field Description: Char (2) Field Name: … Field Description: Char (10) Field Name: AgeInYears Definition: Age of death by single year. … The data files were downloaded by calendar year.

25. Rapid Evidence Product: Adverse Events Associated With COVID-19 Pharmaceutical Treatments (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments-rapid-review.pdf
    March 01, 2024 - Methods The section contains a summary of the project methods; a full description is available as … A-3 The following data were abstracted: • Study identifier (author) and publication year • Study … No. 24-EHC011 March 2024 C-2 Author, Year Related Studies Trial ID Location Setting … No. 24-EHC011 March 2024 C-3 Author, Year Related Studies Trial ID Location Setting … No. 24-EHC011 March 2024 C-4 Author, Year Related Studies Trial ID Location Setting

26. Comparative Effectiveness of Treatments for Cryptorchidism | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/undescended-testicle/research-protocol
    September 02, 2011 - We set a cut-off year of 1980 for all included publications. … evidence table may vary by KQ as appropriate, but the tables will contain some common elements, such as author … , year of publication, study location (e.g., country, city, state) and time period, population description … J Urol 2008;180:783-4; author reply 784-5. PMID: 18555491. Wood HM, Elder JS. … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description

27. Appendices A-E (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/healthcare-system-appendixes-draft-technical-brief.pdf
    February 01, 2023 - ethnic disparities and improve health and healthcare outcomes targeted at healthcare system-level Author … (year) Search date Interventions(s) Chronic Condition(s) Target Population (Race/Ethnicity) … E-7 Author (year) Search date Interventions(s) Chronic Condition(s) Target Population (Race/ … interventions do not address the complex sets of exposures and psychological stress resulting E-8 Author … (year) Search date Interventions(s) Chronic Condition(s) Target Population (Race/Ethnicity)

28. Retention Strategies for Medications for Addiction Treatment in Adults With Opioid Use Disorder: A Rapid Evidence Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/mat-retention-strategies-rapid-review-1.pdf
    August 01, 2020 - Published literature on care settings, services, and logistical support Topic Author, Year, Study … Published literature on extended-release medication based treatments Author, Year Study Design … KQ3: Not reported Fair B-23 Author, Year Study Design Country Funder Number of … Quality ratings for contingency management Author, Year Randomization Allocation Concealment … Quality ratings for psychosocial Author, Year Randomization Allocation Concealment Groups

29. Treatment of Stages I-III Squamous Cell Anal Cancer: A Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/anal-cancer-draft-report.pdf
    October 31, 2023 - This report is made available to the public under the terms of a licensing agreement between the author … We extracted data elements such as author, year of publication, funding source, setting, subject inclusion … Definitions for acute versus late harms varied between studies; we extracted data for harms using author … to year five, then yearly thereafter. … year 2 vs. years 3 to 5; to justify reducing frequency of screening beyond 2nd year.

30. Disposition of comments for CER 169 Low Back Pain (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/back-pain-treatment_disposition-comments.pdf
    February 29, 2016 - Methods Peer Reviewer #3 Here the authors define short-term as <6 mo. and long-term >1 year. … We added a description of Motor Control Exercise in the Results section. … We corrected the publication year for the Henschke review. … repeated and updated the findings of the APS/ACP reviews conducted a few years ago by the same lead author … authors make this statement and provide two citations, both of which were articles authored by the author

31. Disposition of Comments Report for Antiplatelet and Anticoagulant Treatments for Unstable Angina/Non-ST Elevation Myocardial Infarction (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/angina-heart-attack-treatments_disposition-comments.pdf
    January 01, 2014 - In both instances, this description is accurate. TEP Member 1 Executive Summary ES-16. … There is a description of the problem. … year) Major bleeding at 30 days 1 year Total mortality at 30 days 1 year Nonfatal MI at 30 days 1 year … 1 year) Major bleeding at 30 days 1 year Weight ? … of a target audience in the description of the Effective Health Care Program.

32. Disposition of Comments for CER 178 Newer Medications for Lower Urinary Tract Symptoms (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/prostatic-hyperplasia-medications_disposition-comments.pdf
    May 26, 2016 - Very clear description of the different SoE definitions. … TEP Reviewer #4 Methods The criterion for eligible long-term studies of adverse events (> 1 year) … definition of long term to methods section: “We additionally searched for large (n≥100), longer-term (>1 year

33. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/undescended-testicle_research-protocol.pdf
    September 02, 2011 - We set a cut-off year of 1980 for all included publications. … evidence table may vary by KQ as appropriate, but the tables will contain some common elements, such as author … , year of publication, study location (e.g., country, city, state) and time period, population description … the ability to apply the intervention to other populations or other settings, such as inadequate description … J Urol 2008;180:783-4; author reply 784-5. PMID: 18555491. 13. Wood HM, Elder JS.

34. Disposition of Comments for CER 177 Agitation Aggression Dementia (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/dementia-agitation-aggression_disposition-comments.pdf
    March 21, 2016 - Allen Power, author of the two excellent books Dementia Beyond Drugs and Dementia Beyond Disease, in … Aromatherapy is much more than the description used in the review. … A more detailed description of the interventions are available in the full report. … We have enhanced the description of agitation/aggression in the introduction. … Nonpharmacological Interventions Do Not WorkThis provocative heading may seem out of line for the author

35. Medical Therapies for Children With Autism Spectrum Disorder—An Updaterum Disorder--An Update (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/asd-medical-disposition.pdf
    May 26, 2017 - The excluded studies appendix is organized by year and then alphabetically. … There is a short but concise description of ASD and the problems associated with the condition. … We did not set specific parameters for small, medium, or large; we acknowledge that our description … TEP Reviewer #5 Results I am not sure from the description why melatonin is not low SOE. … Discussion/Conclu sion Finally, ref. 42 is not correct – it is to an RCT protocol by the same author

36. Making Healthcare Safer IV: Fatigue and Sleepiness of Clinicians Due to Hours of Service (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/fatigue-sleepiness-protocol.pdf
    July 01, 2023 - reviewed by a single team member to confirm eligibility and prepare a summary of the study, including author … , year, study design, number of study participants, and main findings relevant to the review questions … To describe eligible systematic reviews, a single team member will prepare a summary including the author … , year, number of studies by study design, and main findings relevant to each of our review questions … Inclusion and Exclusion Criteria Literature Searches for Studies of Effectiveness Description of Included

37. Observational Studies: Empirical Evidence of Their Contributions to Comparative Effectiveness Reviews (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/observational-studies_white-paper.pdf
    December 01, 2013 - CER, including the clinical area, type of intervention (e.g., drug, surgery, nonpharmacological), year … Characteristics of included comparative effectiveness reviews (continued) CER Number, Author, Date, … Characteristics of included comparative effectiveness reviews (continued) CER Number, Author, Date, … Characteristics of included comparative effectiveness reviews (continued) CER Number, Author, Date, … Cover Page CER no.: First author (e.g., Lin MA): Date (e.g., 2013-06): EPC (e.g., Alberta): AHRQ

38. EHC Research Protocol: Documentation Burden (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/documentation-burden-protocol.pdf
    July 26, 2023 - Guiding Questions Description/Overview of measurements of documentation burden: 1) What metrics of … We will limit the literature search to studies published after the year 2000. Table 1. … Information Management We will develop a standardized data extraction form to extract study characteristics (author … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description … Guiding Questions Description/Overview of measurements of documentation burden: Factors influencing

39. Technical-Brief-31-Mobile-Health-Applications-For-Self-Management-Of-Diabetes (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/tech-brief-31-mobile-applications-self-mgmt.pdf
    May 01, 2018 - Study details for apps for type 1 diabetes App Name Author & Year Length of Study ROB Assessment … Study details for apps for type 2 diabetes App Name Author & Year Length of Study ROB Assessment … NA C-10 App Name Author & Year Length of Study ROB Assessment Participants Intervention … NA C-12 App Name Author & Year Length of Study ROB Assessment Participants Intervention … NA C-14 App Name Author & Year Length of Study ROB Assessment Participants Intervention

40. Topic Suggestion Description | Effective Health Care Program
    effectivehealthcare.ahrq.gov/get-involved/nominated-topics/1-which-patients-benefit-the-most-from-mtm-services-11-which-factors-or-combinations-of-factors-are-most-predictive-of-the-clinical-benefit-of-mtm-services-111-disease-factors-eg-diabetes-vs-copd-multi-morbidity-vs-single-dis
    July 28, 2010 - Home » Get Involved » Nominated Topics » Topic Suggestion Description … Topic Suggestion Description Date submitted: July 28, 2010 Briefly describe a specific … 3503), but has not appropriated the funds to carry out the MTM grants program in the current fiscal year … Nominator Information Other Information About You: (optional) Please choose a description that